[ Price : $8.95]
FDA publishes statistics on real-world evidence submissions to CBER and CDER in FY 2024 compared to the previous year.[ Price : $8.95]
FDA posts an online notice explaining CDERs Bayesian Statistical Analysis demonstration project.[ Price : $8.95]
The Federal Trade Commission and Justice Department announce three live-streamed listening sessions on aspects of the effort to cu...[ Price : $8.95]
FDA approves an AbbVie expanded label for Mavyret (glecaprevir/pibrentasvir) to include treating adults and pediatric patients thr...[ Price : $8.95]
FDA approves a Nuvation Bio NDA for Ibtrozi (taletrectinib), a kinase inhibitor for adults with locally advanced or metastatic ROS...[ Price : $8.95]
FDA commissioner Marty Makary says the agency will improve the communication channels between reviewers and companies to help spee...[ Price : $8.95]
FDA says it has made labeling changes to fenofibrates as requested in a Healthy Women petition and does not see a need for additio...[ Price : $8.95]
Based on safety concerns, FDA places a clinical hold on Gileads HIV treatment trials of GS-1720, an investigational integrase stra...